Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | TRLV Trulieve Cannabis Corp. Subordinate Voting | ABBV AbbVie |
|---|---|---|
| Price | $10.87 -12.4% | $259.93 -1.3% |
| StockIQ Score | 57C Moderate Risk: Medium | 48D+ Moderate Risk: High |
| Technical | 53C- | 41D |
| Fundamental | 49D+ | 57C |
| Growth | 68B- | 34F |
| Fair Value | 62C+ | 33F |
| News | 74B | 98A+ |
| Quality | 47D+ | 42D |
| Risk | 46D+ | 44D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Trulieve (TRLV) outperforms AbbVie (ABBV) in growth and valuation, with scores of 68 and 62 versus 34 and 33. AbbVie leads in fundamental strength at 57 compared to TRLV’s 49. Both share a moderate investor rating, but TRLV’s technical score (53) is higher than AbbVie’s (41). TRLV excels in areas tied to expansion potential, while AbbVie holds an edge in core business stability.
